About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
AIDS Research and Human Retroviruses
›
Top Articles
AIDS Research and Human Retroviruses
Biology
,
Microbiology
,
Immunology
,
Virology
1.6
(top 11%)
Impact Factor
1.8
(top 11%)
extended IF
115
(top 3%)
H-Index
2.9K
authors
7.1K
papers
139.3K
citations
5.1K
citing journals
33.8K
citing authors
Most Cited Articles of AIDS Research and Human Retroviruses
Title
Year
Citations
Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning
1995
699
A modified bootscan algorithm for automated identification of recombinant sequences and recombination breakpoints
2005
615
Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization
1994
464
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
2001
436
The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection
2004
382
A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion
1993
373
A general model for the transmembrane proteins of HIV and other retroviruses
1989
343
Complete nucleotide sequences of functional clones of the AIDS virus
1987
324
The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus
1990
319
Virologic and immunologic determinants of heterosexual transmission of human immunodeficiency virus type 1 in Africa
2001
311
The HIV-1 protease as a therapeutic target for AIDS
1992
310
A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1
1994
308
Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence
2002
300
Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1
2001
290
Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection
1996
290
Programmed cell death in AIDS-related HIV and SIV infections
1993
290
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid
2009
282
Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody
1987
257
HIV inhibitors targeted at the reverse transcriptase
1992
253
The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?
1991
241
Short communication: transmission of hepatitis B viruses with lamivudine resistance mutations in newly diagnosed HIV individuals
2009
236
V3: HIV's switch-hitter
2005
234
Genetic variants of HIV-1 in Thailand
1992
232
Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines
1993
231
A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities
1996
216
previous
1991
1992
1993
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.